Video Sep 11, 2024
A Medical Consult with GPT-4
Robert Wachter, MD, consults ChatGPT regarding a challenging patient case during the TDC Group 2024 Executive Advisory Board Meeting. Dr. Wachter is an Internist; Chair, Department of Medicine, University of California, San Francisco; and Member of the Board of Governors for The Doctors Company, part of TDC Group.
Search
November 01, 2023, Healthcare Risk Management
Be Prepared to Secure All Types of Evidence After Adverse Events
Richard F. Cahill, Esq., Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses the importance of healthcare providers preparing policies and procedures for securing evidence after adverse events.
Donovan Weger
Donovan Weger, chief operating officer of Gallagher Healthcare in Houston, Texas, has more than 16 years of medical malpractice insurance experience in the areas of claims, sales, and underwriting.
Mar 20, 2019
Study of Malpractice Claims Involving Children
The Doctors Company analyzed 1,215 claims filed on behalf of pediatric patients that closed from 2008 through 2017. The study is based on the claims filed against physicians in 52 specialties and subspecialties and includes an overview of the most common types of claims, expert insights into the specific elements that led to patient injury, and risk mitigation strategies.
2024 AM Best Ratings
September 30, 2024: AM Best has affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and its long-term issuer credit rating (ICR) of "a+”. The outlook of these ratings is stable.
July 30, 2024, Vidrio Improving Alpha Podcast
Improving Alpha: TC Wilson on Advancing the Practice of Good Medicine through Better Asset Allocation Strategies
TC Wilson, Chief Investment Officer of The Doctors Company, part of TDC Group, discusses his journey and the balancing of investments and underwriting to help generate alpha.
AM Best Affirms 2023 A Ratings
September 6, 2023: AM Best has affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and its long-term issuer credit rating (ICR) of "a+”. The outlook of these ratings is stable.
Jun 18, 2024
From the President: TDC Group Appoints Daniel Kent Cassavar, MD, MBA, as Medical Director
President Robert E. White, Jr., announces the appointment of Daniel Kent Cassavar, MD, MBA, as Medical Director of TDC Group.
From
The Doctor’s Advocate
Video Aug 29, 2025
Early Days of Generative AI in Healthcare
Robert M. Wachter, MD, Internist; Chair, Department of Medicine, UCSF; and Member, Board of Governors, The Doctors Company, presents at the 2025 TDC Group Executive Advisory Board Meeting about how healthcare has been transformed in the early days of artificial intelligence.
Mar 07, 2025
Foundation Accepting Letters of Intent for 2025 Grants
The Doctors Company Foundation is currently accepting Letters of Intent for its 2025 grant cycle. Letters of Intent will be accepted through the end of business on Wednesday, March 19, 2025.
From
The Doctor’s Advocate
